Thursday, May 30, 2019

Lupin#39;s Goa facility may face regulatory action, says USFDA

Lupin#39;s Goa facility may face regulatory action, says USFDA The company has received a letter from the US Food and Drug Administration (USFDA) classifying the inspection conducted at its Goa facility between January 28 to February 8 as Official Action Indicated (OAI), Lupin said in a regulatory filing.

from Moneycontrol Business News http://bit.ly/2Z0UEHU
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Oil Price Today (March 25): Oil slips below $100 on rising hopes of Iran war ceasefire. Here’s what experts are saying

Oil prices saw a significant drop as hopes for a ceasefire in the Middle East grew. Reports suggested a U.S. proposal aimed at ending the co...